Abstract
The number of patients with type 2 diabetes requiring insulin treatment significantly increases, and today, there are many more patients with type 2 diabetes, than ones with type 1 diabetes. Currently, more than 30% of all patients with type 2 diabetes receive insulin. At the same time, indications for insulin institution and choice of tactics of insulin therapy in type 2 diabetes are not as unambiguous as in type 1 diabetes. Schemes of insulin therapy and its institution are key issues today.
References
1. IDF Diabetes Atlas, 2010.
2. Дедов И.И., Шестакова М.В. Сахарный диабет. Руководство для врачей. М.: 2003. - 526 с.
3. Defronzo R.A., Bonadonna R.S. Diabetes mellitus 1992 - 15. Р. 318-368 .
4. Lazio S.D., Dunseath G., Lockett A. еt al. Comparison of an oral insulin (capsulin) and actrapid an isoglycaemic clamp study in persons with type 2 diabetes // Diabetes - 2007 - Vol. 66 - Suppl. 1 - P. A10.
5. Diabetes Control and complications trial research group. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus // Arch Ophthalmol – 1995 - Vol. 113. - P. 36-51.
6. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment of risk of complications in patients with type 2 diabetes (UKPDS 33) // Lancet. - 1998. - Vol. 352. - P. 837-853.
7. UK Prospective Diabetes Study (UKPDS) Group. Effects of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) // Lancet. - 1998. - Vol. 352. - P. 854-865.
8. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complication-Part 1: Diagnosis and classification of
diabetes mellitus, Geneva: WHO, 1999.
9. American Diabetes Association. Standards of medical care in diabetes // Diabetes Care - 2007 - Vol.30. - Suppl. 1, S1-S-103.
10. Сегіеllо A. // Diabetologie, 2003, 46 (Suppl.l) M9.
11. Rossetti L. // Clin Invest Med - 1995 - 18; 255-260.
12. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. // lancet - 1998 - 352:854-865.
13. Intensive btood-glucose control with sulphonyiureos or insulin compared with conventional Ireolmeni and risk of complications in patients with typo 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. // Lancet - 1998 - 352: 837-853.
2. Дедов И.И., Шестакова М.В. Сахарный диабет. Руководство для врачей. М.: 2003. - 526 с.
3. Defronzo R.A., Bonadonna R.S. Diabetes mellitus 1992 - 15. Р. 318-368 .
4. Lazio S.D., Dunseath G., Lockett A. еt al. Comparison of an oral insulin (capsulin) and actrapid an isoglycaemic clamp study in persons with type 2 diabetes // Diabetes - 2007 - Vol. 66 - Suppl. 1 - P. A10.
5. Diabetes Control and complications trial research group. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus // Arch Ophthalmol – 1995 - Vol. 113. - P. 36-51.
6. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment of risk of complications in patients with type 2 diabetes (UKPDS 33) // Lancet. - 1998. - Vol. 352. - P. 837-853.
7. UK Prospective Diabetes Study (UKPDS) Group. Effects of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) // Lancet. - 1998. - Vol. 352. - P. 854-865.
8. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complication-Part 1: Diagnosis and classification of
diabetes mellitus, Geneva: WHO, 1999.
9. American Diabetes Association. Standards of medical care in diabetes // Diabetes Care - 2007 - Vol.30. - Suppl. 1, S1-S-103.
10. Сегіеllо A. // Diabetologie, 2003, 46 (Suppl.l) M9.
11. Rossetti L. // Clin Invest Med - 1995 - 18; 255-260.
12. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. // lancet - 1998 - 352:854-865.
13. Intensive btood-glucose control with sulphonyiureos or insulin compared with conventional Ireolmeni and risk of complications in patients with typo 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. // Lancet - 1998 - 352: 837-853.
Downloads
Download data is not yet available.